• Users Online: 142
  • Print this page
  • Email this page
Year : 2018  |  Volume : 1  |  Issue : 1  |  Page : 6-12

Expert-Based strategies to improve access to cancer therapeutics at the hospital level

1 Department of Oncology, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Science, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
2 Department of Pharmacy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
3 Drug Policy and Economics Center, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
4 Department of Pharmacy, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
5 Department of Oncology, King Khalid University Hospital, Riyadh, Saudi Arabia
6 Department of OB and GYN, Certified Breast Cancer Center, Certified Cancer Center, Certified Endometriosis Center, Certified Dysplastic Unit, AGAPLESION Markus Krankenhaus, Frankfurt, Germany

Correspondence Address:
Abdul Rahman Jazieh
Department of Oncology, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/JQSH.JQSH_4_18

Get Permissions

Background: Challenges related to access to cancer medications is an increasing global problem that has far-reaching impact on patients and healthcare systems. In this article, we are enlisting suggested solutions at the hospital or practice level to maximize the access to these important treatment modalities. Methods: An expert panel of practicing oncologists, clinical pharmacists, and health economists convened using a framework approach. The panelists identified individuals and entities that impact the use of cancer therapeutics and how they can improve the utilization and access to them. They enlisted the potential actions that hospital management and staff can take to enhance access to cancer therapeutics, then they grouped them into specific categories. Results: List of potential strategies and related action items were compiled into different categories including hospital leadership, drug evaluation entities, pharmacy, physicians, patients and families, and other parties. Recommendations included various actions to be considered by each group to achieve set goals. Conclusion: Our expert panel recommend multiple strategies and approaches to reduce the cost of cancer medications and improve patients' access to them. These recommendations can be adapted by the decision-makers and staff of the hospitals to their own settings and the current circumstances.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded167    
    Comments [Add]    

Recommend this journal